COVIVAC uses viral vector technology on primary chicken embryo cell culture - a technique IVAC used previously to successfully produce seasonal flu vaccines. It is preserved at temperatures from 2-8 degrees Celsius.

leftcenterrightdel
(Photo for illustration)

In the first phase, it was evaluated as safe, well-tolerant and immunogenic.

The second phase will be carried out in Vu Thu district, northern Thai Binh province, with 375 volunteers.

COVIVAC is the second “made-in-Vietnam” vaccine to be allowed for clinical trials by the Health Ministry, following Nanogen company’s NanoCovax.

Source: VNA